Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101 | Tivoli A/S (TIV.CO) | XCSE | DK | 2023-12-31 | 2 days ago | DKK | 726.00 | 162.69 | 22.41% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 102 | Novo Nordisk A/S (NOVO.B.CO) | 2019-12-31 | 3 years ago | DKK | 431.95 | 94.09 | 21.78% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 103 | ALK-Abello A/S (ALK B.CO) | XCSE | DK | 2023-12-31 | 2 days ago | DKK | 152.40 | 26.62 | 17.47% | 3.11 | 2.04% | NCAV (Net-Net) | 3.11 | 2.04% |
| 104 | Ambu A/S (AMBU B.CO) | XCSE | DK | 2023-09-30 | 2 days ago | DKK | 116.70 | 17.38 | 14.90% | 2.04 | 1.74% | NCAV (Net-Net) | 2.04 | 1.74% |
| 105 | Torm PLC (TRMD.A.CO) | 2019-12-31 | 3 years ago | DKK | 43.60 | 5.88 | 13.48% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 106 | Genmab A/S (GMAB.CO) | XCSE | DK | 2023-12-31 | 2 days ago | DKK | 2,004.00 | 266.28 | 13.29% | 45.56 | 2.27% | NCAV (Net-Net) | 45.56 | 2.27% |
| 107 | Coloplast A/S (COLO.B.CO) | 2019-09-30 | 3 years ago | DKK | 926.60 | 116.91 | 12.62% | 2.54 | 0.27% | NCAV (Net-Net) | 2.54 | 0.27% | ||
| 108 | Novo Nordisk A/S (NOVO B.CO) | XCSE | DK | 2023-12-31 | 2 days ago | DKK | 851.40 | 85.93 | 10.09% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 109 | Cbrain A/S (CBRAIN.CO) | XCSE | DK | 2023-12-31 | 2 days ago | DKK | 291.00 | 24.38 | 8.38% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 110 | Ambu A/S (AMBU.B.CO) | 2019-09-30 | 3 years ago | DKK | 246.10 | 17.19 | 6.98% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |